| PubMed |
Abstract |
RScore(About this table) |
| 2367521 |
Brown JM, White CW, Terada LS, Grosso MA, Shanley PF, Mulvin DW, Banerjee A, Whitman GJ, Harken AH, Repine JE: Interleukin 1 pretreatment decreases ischemia/reperfusion injury. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5026-30.
|
5(0,0,0,5) |
Details |
| 9037247 |
Renard P, Zachary MD, Bougelet C, Mirault ME, Haegeman G, Remacle J, Raes M: Effects of antioxidant enzyme modulations on interleukin-1-induced nuclear factor kappa B activation. Biochem Pharmacol. 1997 Jan 24;53(2):149-60.
|
3(0,0,0,3) |
Details |
| 9685387 |
Singh I, Pahan K, Khan M, Singh AK: Cytokine-mediated induction of ceramide production is redox-sensitive. J Biol Chem. 1998 Aug 7;273(32):20354-62.
Treatment of rat primary astrocytes with tumor necrosis factor-alpha (TNF-alpha) or interleukin-1beta led to marked alteration in cellular redox (decrease in intracellular GSH) and rapid degradation of SM to ceramide. |
1(0,0,0,1) |
Details |
| 8865862 |
Korybalska K, Breborowicz A, Martis L, Oreopoulos DG: In vitro detection of hydrogen peroxide in mesothelial cells. Adv Perit Dial. 1996;12:7-10.
However, interleukin-1 (IL-1) (10 ng/mL) enhances, within two hours (+40%, p < 0.05), intracellular production of hydrogen peroxide. |
1(0,0,0,1) |
Details |